U.S. markets close in 5 hours 28 minutes

Alternate Health Corp. (AHG.CN)

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Add to watchlist
0.10000.0000 (0.00%)
As of 12:02PM EDT. Market open.
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1000
Bid0.0950 x 0
Ask0.0950 x 0
Day's Range0.1000 - 0.1000
52 Week Range0.0500 - 0.2300
Avg. Volume0
Market Cap7.788M
Beta (5Y Monthly)-0.81
PE Ratio (TTM)N/A
EPS (TTM)-0.2440
Earnings DateJul 30, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • CNW Group

      IIROC Trading Halt - AHG

      IIROC Trading Halt - AHG

    • Did You Manage To Avoid Alternate Health's (CSE:AHG) 96% Share Price Wipe Out?
      Simply Wall St.

      Did You Manage To Avoid Alternate Health's (CSE:AHG) 96% Share Price Wipe Out?

      As an investor, mistakes are inevitable. But you want to avoid the really big losses like the plague. So spare a...

    • Newsfile

      Alternate Health's CBD Business Arrives in Asia

      Toronto, Ontario--(Newsfile Corp. - March 17, 2020) - Alternate Health Corp., (CSE: AHG) (OTCQB: AHGIF) ("Alternate Health" or the "Company"), an international leader in CBD product development and distribution, announced today that the Company has signed an exclusive sales agreement with Interadigm Shd. Bhd. ("Interadigm") to market the Company's online CBD education program throughout Malaysia, with ongoing negotiations to expand into clinical trials and CBD product distribution."As we have seen from the excitement created ...